rss
BMJ Case Reports 2012; doi:10.1136/bcr.01.2012.5644
  • Findings that shed new light on the possible pathogenesis of a disease or an adverse effect

Complication of etanercept treatment for rheumatoid arthritis – purulent pericarditis caused by a commensal organism

  1. Shiu Shing Soo1
  1. 1Microbiology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK
  2. 2Cardiology Department, Nottingham University Hospitals NHS Trust, Nottingham, UK
  1. Correspondence to Dr Shiu Shing Soo, shing.soo{at}nuh.nhs.uk

Summary

The patient presented with increasing fatigue and dyspnoea. The patient had medical history of rheumatoid arthritis for which she had been taking methotrexate for the past 15 years and etanercept for the past 6 years. Initial diagnosis was cardiac failure but further investigation by echocardiogram revealed a large pericardial effusion. Empirical piperacillin-tazobactam was started due to moderately raised inflammatory markers. Four hundred millilitre of frank pus was aspirated from the pericardial sac and antimicrobial treatment was changed to meropenem. Gram positive cocci were seen in the initial Gram stain, but conventional cultures remained negative. However, 16S ribosomal RNA gene sequencing of the pus sample detected the presence of Parvimonas micra genome. Reaccumulation of the effusion required further drainage where again P micra was detected by 16S ribosomal RNA gene sequencing. Two weeks of meropenem was completed followed by treatment with benzylpenicillin and metronidazole.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article